From Name

From Email

To Name

To Email

Message

Long-acting injectable form of HIV prevention outperforms daily pill

from National Institute of Allergy and Infectious Diseases via ScienceDaily

Long-acting injectable form of HIV prevention outperforms daily pill National Institute of Allergy and Infectious Diseases via ScienceDaily A pre-exposure prophylaxis regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every eight weeks was more effective than daily oral Truvada at preventing HIV acquisition among cisgender men who have sex with men and transgender women who have sex with men in a recent clinical trial. Findings are from the Phase 2b/3 study, called HPTN 083. READ MORE

more